Michael Elgort
@Parkman Healthcare Partners Llc
Latest period2024 - Q3ReportedManaged Assets$783.443MTotal holdings93
Assets growth rate4.94%Assets growth rate (2-Q avg)-1.72%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Parkman Healthcare Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.
Assets under management
The assets under management (AUM) of Parkman Healthcare Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 783.443M in assets, with a quarterly growth rate of 4.94% and a 2-quarter average growth rate of -1.72%. The portfolio is managed by Michael Elgort, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BSXBoston Scientific Corp
| 4.79% | $37.475M 447,196 shares@ $83.81 avg price | Decreased -18.92% |
PODDInsulet Corp
| 4.75% | $37.168M 159,689 shares@ $232.76 avg price | Decreased -10.94% |
LLYEli Lilly & Co
| 4.57% | $35.778M 40,384 shares@ $885.95 avg price | Increased 27.58% |
COOCooper Cos Inc
| 4.13% | $32.285M 292,593 shares@ $110.35 avg price | Decreased -5.12% |
KROSKeros Therapeutics Inc
| 3.13% | $24.493M 421,782 shares@ $58.08 avg price | Increased 112.35% |
TFXTeleflex Incorporated
| 3.04% | $23.778M 96,144 shares@ $247.32 avg price | New Position |
UTHRUnited Therapeutics Corp Del
| 2.93% | $22.946M 64,031 shares@ $358.36 avg price | Decreased -42.51% |
MNKDMannkind Corp
| 2.66% | $20.783M 3.304M shares@ $6.3 avg price | Increased 37.13% |
KNSAKiniksa Pharmaceuticals Intl
| 2.41% | $18.874M 755,244 shares@ $25.0 avg price | Increased 16.71% |
VRNAVerona Pharma Plc
| 2.31% | $18.023M 626,452 shares@ $28.77 avg price | Increased 5.22% |